Get the latest Science News and Discoveries
Glenmark Pharmaceuticals launches Tevimbra lung cancer immunotherapy in India, expands oncology portfolio
Glenmark Pharmaceuticals introduces Tevimbra (tislelizumab), a PD‑1 immunotherapy for lung cancer, to its India oncology portfolio under its BeiGene partnership
None
Or read this on r/EverythingScience